吉利汽車(00175.HK)推首款具「N95口罩級」淨化濾芯防疫車 暫接逾3萬張訂單
吉利汽車(00175.HK)昨日(24日)正式推出配備「CN95高效複合空調濾芯」的「防疫車」,該車款命名為「ICON」,屬運動型多用途車(SUV)車型,售價介乎11.58萬至12.88萬元人民幣,目前已接獲超過3萬張訂單。
為應對新型冠狀肺炎,吉利將內地首個以「N95口罩」為過濾標準的車載高效復合空調濾芯安裝在「ICON」新車。該套系統能有效淨化車內空氣,除常規逐級過濾粉塵、有害氣體、PM2.5顆粒外,對粒徑0.3微米以上顆粒粉塵的過濾效率達95%以上,達到「N95口罩」級別的淨化效果,相當於為汽車戴上「N95口罩」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.